This inventor holds 1 USPTO granted patent. Top assignee: Sungkwang Medical Foundation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by Tae Heon Kim in Cancer Treatment
Introduction
Tae Heon Kim is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of cancer treatment, particularly in addressing the challenges posed by taxane anticancer agent-resistant cancers. His innovative work has led to the development of a unique composition, kit, and method aimed at diagnosing and treating these resistant forms of cancer.
Latest Patents
Tae Heon Kim holds a patent for a composition, kit, and method for the diagnosis and treatment of taxane anticancer agent-resistant cancer. This patent outlines a composition for diagnosing resistance to taxane anticancer agents, as well as a method for screening materials that may effectively treat these resistant cancers. His work provides a promising avenue for efficiently diagnosing and treating patients who are resistant to traditional taxane therapies.
Career Highlights
Tae Heon Kim is associated with the Sungkwang Medical Foundation, where he continues to advance his research and innovations in cancer treatment. His dedication to improving patient outcomes through innovative solutions is evident in his work and contributions to the medical field.
Collaborations
He collaborates with esteemed colleagues, including Hee Jung An and Hae Youn Kang, who share his commitment to advancing cancer treatment methodologies. Their combined expertise enhances the potential for groundbreaking discoveries in the fight against cancer.
Conclusion
Tae Heon Kim's innovative contributions to cancer treatment highlight the importance of research and development in overcoming medical challenges. His work not only addresses the pressing issue of drug resistance in cancer therapy but also paves the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile